SYMPATHY: Renal sympathetic denervation as a new treatment for therapy resistant hypertension: from rescue to resolve. - SYMPATHY

niversitair Medisch Centrum Utrecht0 个研究点目标入组 260 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•1.Individual has a mean daytime SBP >= 135 mmHg determined with the use of 24-h or daytime ambulatory BP monitoring while the individual uses antihypertensives.
•2.Individual uses at least 3 antihypertensive drugs.
•3.Individual is >=18 years of age.

•1. Individual is unable or unwilling to sign informed consent
•2. Individual has a treatable secondary cause of hypertension
•3. Individual has an eGFR below 20mL/min/1.73m2 using the MDRD calculation
•4. Individual has renal artery anatomy that is ineligible for treatment
•5. Individual has any serious medical condition, which in the opinion of the investigator, may adversely affect the safety and/or effectiveness of the participant or the study
•6. Individual is pregnant, nursing or planning to be pregnant.
•7. Individual has a known, unresolved history of drug use or alcohol dependency, lacks the ability to comprehend or follow instructions, or would be unlikely or unable to comply with study follow-up requirements.
•8. Individual is currently enrolled in another investigational drug or device trial.

发起方

niversitair Medisch Centrum Utrecht